Urokinase plasminogen activator (uPA) and matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9, participate in the degradation of the extracellular matrix and are therefore closely related to the occurrence and development of cancer [86, 87]. The gene discussed is PLAU; the disease is cancer.